Androgen-deprivation therapy in prostate cancer and cardiovascular risk: a science advisory from the American Heart Association, American Cancer Society, and American Urological Association: endorsed by the American Society for Radiation Oncology

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Circulation (New York, N.Y.) N.Y.), 2010-02, Vol.121 (6), p.833-840
Hauptverfasser:	Levine, Glenn N, D'Amico, Anthony V, Berger, Peter, Clark, Peter E, Eckel, Robert H, Keating, Nancy L, Milani, Richard V, Sagalowsky, Arthur I, Smith, Matthew R, Zakai, Neil
Format:	Artikel
Sprache:	eng
Schlagworte:	Advisory Committees American Cancer Society American Heart Association Androgen Antagonists - adverse effects Androgen Antagonists - therapeutic use Cardiovascular Diseases - epidemiology Gonadotropin-Releasing Hormone - agonists Humans Male Prostatic Neoplasms - drug therapy Risk Factors Societies, Medical United States
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!